$EDVA News

Endovia Health Sciences Announces U.S. Drug Enforcement Administration’s Decision To Transfer Marijuana From Schedule I To Schedule II Of Controlled Substances Act; Co. Plans To File Pre-Submission Conference With FDA For CannEpil

Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program

Endovia Health Sciences Says FDA Center For Veterinary Medicine Established Investigational New Animal Drug File No. 14145 For CannEpil In Canine Cancer-Related Pain

Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday

Splash Beverage Group Q2 EPS $(0.77) Up From $(17.88) YoY, Sales $0.00, Same YoY

Splash Beverage Group Files Prospectus Related To Resale Of Up To 5M Shares By Selling Stockholder

Splash Beverage Collaborates With Lupvindol To Advance CannEpil As Potential FDA-Regulated Veterinary Pharma Product For Companion-Animal Oncology And Chronic Pain Management

Splash Beverage Group (SBEV) Stock Is Trending Overnight— Here's Why It Jumped 64% After Hours

Splash Beverage Expands Exclusive Global License For CannEpil To Include Veterinary Therapeutic Applications

Splash Beverage Group Amends Settlement Agreements With Three Prior Investors On July 15

Splash Beverage Settles $3.3M Liabilities For $550K, Expects $2.75M Gain; Board Approves 1‑For‑4 Reverse Stock Split To Advance NYSE Compliance Plan

Splash Beverage Group Receives NYSE American Compliance Plan Extension Through Jan. 29, 2027

Splash Beverage Enters Into Exclusive Global Licensing Agreement With Argent BioPharma For CannEpil, Proprietary Epilepsy Therapy

What's Going On With Splash Beverage Stock Thursday?

Splash Beverage Submits NYSE American Compliance Plan, Awaits Exchange Decision; Co. Says Medterra CBD LOI Expired; Continues Talks With Multiple Cannabinoid Wellness Partners

Splash Beverage Group Q1 EPS $(0.47) Up From $(1.97) YoY, Sales $4.224K Down From $68.606K YoY

Splash Beverage Group Files For Non-Timely 10-K With U.S. SEC; Expects To Report Revenues For Year Ended December 31, 2025 Of About $0.4M Down From $4.2M YoY

Splash Beverage plans pivot to CBD

Splash Beverage Group Signs Letter of Intent for Acquisition and Merger With Established Hemp and CBD Operator Medterra

Splash Beverage Group Appoints Brady Cobb to Board of Directors as Company Advances Splash 2.0 Strategy